BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KI Science Park - ECPv6.15.0.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KI Science Park
X-ORIGINAL-URL:https://www.kisciencepark.kisciencepark.hemsida.eu
X-WR-CALDESC:Events for KI Science Park
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260422T113000
DTEND;TZID=Europe/Stockholm:20260422T121500
DTSTAMP:20260722T050732
CREATED:20260205T220502Z
LAST-MODIFIED:20260205T220548Z
UID:10000223-1776857400-1776860100@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:BRIDGE Webinar: Preclinical studies
DESCRIPTION:Preclinical studies\n\n\n\nIn this webinar\, LedagoBIO will present key preclinical considerations in drug development\, providing insights into important aspects to address at this stage. \nMore information will come closer to the event. \nRegistration no open yet. \n\nABOUT BRIDGE \nRunning for 3 years and supported by SweLife through the Swedish Innovation Agency\, Vinnova\, BRIDGE aims to create a development platform spanning from identifying drug candidates to production.  Project start: 2024. \nPROJECT PARTNERS \nTesta Center (Project Coordinator): A national “open access” laboratory and production environment for academics and companies looking to verify and upscale their biological process for large-scale production. \nSciLifeLab Drug Discovery and Development Platform (DDD): A national research infrastructure providing state-of-the-art technology and expertise in drug development\, from small molecules\, biological pharmaceuticals\, therapeutic oligonucleotides\, and new modalities\, from concept to preclinical stage. \nStem Cell Center & Pre-GMP Lund University (LU): Conducting research in cell\, tissue\, and gene therapy\, and supporting researchers with pre-GMP services to bridge the gap from research findings to patient care. These units also closely collaborate with the ATMP center (SUS)\, a node for Region Skåne’s work with ATMP treatments. \nSTUNS: Foundation for collaboration between universities in Uppsala\, industry\, and society\, promoting co-creation at the intersection of universities\, industry\, and society to create new opportunities. \nALIS (Association of Life Science Incubators): A national platform that brings together nine regional life science incubators (GU Ventures\, KI Innovations\, Lead\, Medeon\, Sahlgrenska Science Park\, Smile Incubator\, STING\, Umeå Biotech Incubator och Uppsala Innovation Center) tasked with supporting and guiding startups and research groups in skills development\, business development\, coaching\, and access to national and international private capital
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/bridge-webinar-preclinical-studies/
LOCATION:Webinar: Microsoft teams
ATTACH;FMTTYPE=image/jpeg:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2026/02/260422-bridge-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260303T113000
DTEND;TZID=Europe/Stockholm:20260303T121500
DTSTAMP:20260722T050732
CREATED:20260205T215714Z
LAST-MODIFIED:20260205T215714Z
UID:10000222-1772537400-1772540100@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:BRIDGE Webinar: Regulatory Affairs for Biologics
DESCRIPTION:Regulatory Affairs for Biologics\n\n\n\nRegulatory strategy and CMC considerations are fundamental components of biological drug development and can significantly influence the transition from discovery to clinical development. Early alignment on these aspects is critical for de-risking development programs and ensuring regulatory readiness. \nIn this webinar\, Emma Eriksson and Marie Gårdmark from RegSmart Life Science will present key strategic regulatory elements in drug development. The presentation is divided into two parts: the first will address overarching regulatory strategy\, while the second will focus on selected CMC aspects specific to biological drug development. \n\nREGISTER HERE \nABOUT BRIDGE \nRunning for 3 years and supported by SweLife through the Swedish Innovation Agency\, Vinnova\, BRIDGE aims to create a development platform spanning from identifying drug candidates to production.  Project start: 2024. \nPROJECT PARTNERS \nTesta Center (Project Coordinator): A national “open access” laboratory and production environment for academics and companies looking to verify and upscale their biological process for large-scale production. \nSciLifeLab Drug Discovery and Development Platform (DDD): A national research infrastructure providing state-of-the-art technology and expertise in drug development\, from small molecules\, biological pharmaceuticals\, therapeutic oligonucleotides\, and new modalities\, from concept to preclinical stage. \nStem Cell Center & Pre-GMP Lund University (LU): Conducting research in cell\, tissue\, and gene therapy\, and supporting researchers with pre-GMP services to bridge the gap from research findings to patient care. These units also closely collaborate with the ATMP center (SUS)\, a node for Region Skåne’s work with ATMP treatments. \nSTUNS: Foundation for collaboration between universities in Uppsala\, industry\, and society\, promoting co-creation at the intersection of universities\, industry\, and society to create new opportunities. \nALIS (Association of Life Science Incubators): A national platform that brings together nine regional life science incubators (GU Ventures\, KI Innovations\, Lead\, Medeon\, Sahlgrenska Science Park\, Smile Incubator\, STING\, Umeå Biotech Incubator och Uppsala Innovation Center) tasked with supporting and guiding startups and research groups in skills development\, business development\, coaching\, and access to national and international private capital
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/bridge-webinar-regulatory-affairs-for-biologics/
LOCATION:Webinar: Microsoft teams
ATTACH;FMTTYPE=image/jpeg:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2026/02/260303-bridge-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250508T120000
DTEND;TZID=Europe/Stockholm:20250508T125500
DTSTAMP:20260722T050732
CREATED:20250422T131104Z
LAST-MODIFIED:20250422T133250Z
UID:10000143-1746705600-1746708900@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:How startups can avoid the most common mistakes regarding rights & obligations for employers and employees. (Webinar)
DESCRIPTION:As startups grow and hire personnel\, various situations may arise that employers may face. Employment and Labour Law Specialist Anna Welinder at Teknikföretagen will guide you through the most important issues when it comes to rights and obligations for the employees and for you as an employer. \nRegister here! \n  \nThis is a collaboration between SISP (Swedish Incubators & Science Parks)\, STEP & Teknikföretagen \nAnna Welinder at Teknikföretagen will cover\, among other things: \n– Basic rights and obligations in employment.\n– What demands can an employer place on an employee\n– What demands can an employee place on their employer\n– When is an employee entitled to take leave from work\n– How do you handle an employee who is underperforming \nThere is an opportunity to ask questions both before and during the webinar. Please feel free to send your questions in advance to yvonne.lo-alfredsson@teknikforetagen.se \n  \n\nOm SISP \nSwedish Incubators & Science Parks (SISP) är branschorganisationen för Sveriges inkubatorer och science parks. Medlemmarna utgör regionala innovationsmiljöer över hela landet. Sveriges inkubatorer och science parks stödjer tillväxtorienterade\, innovativa företag\, liksom etablerade industrier och offentlig sektor\, för att utveckla ett hållbart samhälle genom innovation. Flera medlemmar driver också affärsängelnätverk och såddkapitalfonder för att investera i tidiga stadier.
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/how-startups-can-avoid-the-most-common-mistakes-regarding-rights-obligations-for-employers-and-employees-webinar/
LOCATION:Webinar: Microsoft teams
ATTACH;FMTTYPE=image/png:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2025/04/skarmavbild-2025-04-22-kl-150811.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250218T100000
DTEND;TZID=Europe/Stockholm:20250218T110000
DTSTAMP:20260722T050732
CREATED:20250127T103439Z
LAST-MODIFIED:20250127T103559Z
UID:10000131-1739872800-1739876400@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:Webinar: SMEs keen to protect your IPRs - Boost your business with EU Funding!
DESCRIPTION:New edition 2025 SME Fund. Boost your business with EU Funding!\nFollowing the success of the SME Fund in past editions\, we are delighted to launch the new SME Fund for 2025! Through this webinar you will: \n\nUnderstand the benefits of the SME Fund for your small or medium-sized business.\nLearn about the support available for safeguarding your intellectual property rights (IPRs) through vouchers.\nDiscover how to apply for the SME Fund and how to obtain partial reimbursement for your IP rights: (trade marks\, designs\, patents and plant varieties) and also for IP Scans.\n\n  \nRegister here! \n  \nThe webinar targets small and medium-sized enterprises (SMEs) based in the EU and Ukraine who are keen to protect their IPRs. It is also available to their representatives. SMEs that applied in previous years are eligible to apply again this year. The Ideas Powered for business SME Fund is an initiative by the European Commission implemented through the European Union Intellectual Property Office (EUIPO). \nYou will find more information on the SME Fund here: https://www.euipo.europa.eu/en/sme-corner \nSpeakers \nTamas KIRALY\, European Commission Elisavet KARAGIAMPI\, Business Development Department\, EUIPO Natalia RUANO BUTLER\, Business Development Department\, EUIPO Francesca CERRI\, Business Development Department\, EUIPO
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/webinar-smes-keen-to-protect-your-iprs-boost-your-business-with-eu-funding/
LOCATION:Webinar: Microsoft teams
ATTACH;FMTTYPE=image/webp:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2025/01/ipr-eu.webp
ORGANIZER;CN="KI Science Park":MAILTO:event@kisciencepark.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20241112T150000
DTEND;TZID=Europe/Stockholm:20241112T160000
DTSTAMP:20260722T050732
CREATED:20241104T085254Z
LAST-MODIFIED:20241104T085254Z
UID:10000113-1731423600-1731427200@www.kisciencepark.kisciencepark.hemsida.eu
SUMMARY:Unlocking NIH Opportunities
DESCRIPTION:How Swedish Companies can Collaborate with the largest Life Science Research Institute in the World\nJoin Business Sweden and the National Institutes of Health (NIH) for an exclusive webinar to explore how Swedish companies can successfully partner with NIH to drive innovation in the US healthcare ecosystem. This session will provide an overview of NIH’s research funding programs\, strategic partnerships\, and the pathways for Swedish businesses to contribute to and benefit from groundbreaking medical and healthcare research together with NIH \nRegister here! \nKey Takeaways \n\nInsights into NIH as a research and commercialization partner\nUnderstanding NIH’s funding mechanisms and eligibility for international companies\nExamples on successful partnerships and collaboration models with NIH\nReview and next steps on how Swedish companies can work with NIH\n\nAbout \nNational Institute of Health:\nThe National Institutes of Health (NIH) is the primary agency of the US government responsible for biomedical and public health research. It funds and conducts critical research aimed at understanding and improving human health\, while fostering collaborations between government\, academic institutions\, and industry to advance medical science and innovation. \nBusiness Sweden:\nBusiness Sweden is commissioned by the Government and the Swedish industry to help Swedish companies grow global sales and international companies invest and expand in Sweden. \nNovadigm Consulting:\nNovadigm Consulting Group provides a wider range of management consulting services to biotechnology companies.
URL:https://www.kisciencepark.kisciencepark.hemsida.eu/event/unlocking-nih-opportunities/
LOCATION:Webinar: Microsoft teams
ATTACH;FMTTYPE=image/jpeg:https://www.kisciencepark.kisciencepark.hemsida.eu/wp-content/uploads/2024/11/241112-bus-webinarie-nih.jpg
END:VEVENT
END:VCALENDAR